These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5958880)
1. [Griseofulvin in the treatment of circumscribed scleroderma]. Capusan I; Pop OM; Pop CS Dermatologica; 1966; 132(4):337-42. PubMed ID: 5958880 [No Abstract] [Full Text] [Related]
2. [Therapy of scleroderma with griseofulvin (author's transl)]. Kobíková M; Stáva Z; Cerná M Cesk Dermatol; 1976 Aug; 51(4):224-6. PubMed ID: 788928 [No Abstract] [Full Text] [Related]
3. [Griseofulvin administered for an indeterminate time in the therapy of systemic scleroderma and Raynaud's syndrome]. Giordano M; Capelli L; Ara M; Tirri G Reumatismo; 1971; 23(2):82-92. PubMed ID: 5146109 [No Abstract] [Full Text] [Related]
4. [Griseofulvin in the treatment of generalized progressive scleroderma and various forms of rheumatic diseases]. Giordano M; Ara M; Capelli L; Tirri G Rhumatologie; 1968 Nov; 20(9):353-9. PubMed ID: 5717870 [No Abstract] [Full Text] [Related]
5. [Griseofulvin in the therapy of scleroderma (preliminary note)]. Pisani M; Biondi C; Mariotti F Minerva Dermatol; 1967 Dec; 42(12):635-7. PubMed ID: 5622845 [No Abstract] [Full Text] [Related]
6. [The effect of procaine, griseofulvin and chloroquine on skin perfusion in progressive scleroderma]. Wiskemann A; Korff F Dermatol Wochenschr; 1967 Sep; 153(37):1033-7. PubMed ID: 5589729 [No Abstract] [Full Text] [Related]
7. [Studies in 25 patients with progressive systemic scleroderma treated by long-term administration of griseofulvin]. Giordano M; Ara M; Capelli L; Tirri G; Pettinato G; Vatti M Minerva Med; 1973 Jun; 64(46):2451-66. PubMed ID: 4579328 [No Abstract] [Full Text] [Related]
8. [On griseofulvin therapy of primary chronic polyarthritis]. Urbaszek W; Luschnitz E Z Rheumaforsch; 1965 Dec; 24(11):416-9. PubMed ID: 5869790 [No Abstract] [Full Text] [Related]
11. [Treatment with Chelaton Polfa of circumscribed scleroderma in a child]. Niewiedziol B; Malczyńska E Pol Tyg Lek; 1968 Sep; 23(39):1487-8. PubMed ID: 4972439 [No Abstract] [Full Text] [Related]
12. [Treatment results with dimethyl sulfoxide in circumscribed scleroderma]. Gärtner R; Flegel H Dermatol Wochenschr; 1968 Oct; 154(43):1015-22. PubMed ID: 5733089 [No Abstract] [Full Text] [Related]
13. [SUCCESSFUL TREATMENT OF DIFFUSE SCLERODERMA WITH GRISEOFULVIN]. BOUR JH; CREMER G Ned Tijdschr Geneeskd; 1963 Nov; 107():2145-6. PubMed ID: 14097769 [No Abstract] [Full Text] [Related]
14. Inhibited proliferation of human scleroderma skin fibroblasts and rheumatoid synovial cells with griseofulvin in vitro. Priestley GC; Brown JC Acta Derm Venereol; 1982; 62(2):167-9. PubMed ID: 6179346 [TBL] [Abstract][Full Text] [Related]
15. [Prognosis and treatment of scleroderma]. Crickx B; Belaich S Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058 [TBL] [Abstract][Full Text] [Related]
16. [Study on the treatment of diffuse scleroderma using Edtacal]. Fedorová O Vnitr Lek; 1966 Jul; 12(7):682-4. PubMed ID: 4961194 [No Abstract] [Full Text] [Related]
17. [The treatment of scleroderma with uropancreozymin]. Kvícalová E; Obrtel J; Stáva Z; Svatos A Cesk Dermatol; 1966 Apr; 41(2):109-14. PubMed ID: 5943477 [No Abstract] [Full Text] [Related]
18. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Alekperov RT; Avdeev SN; Kotovskaia MA Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466 [No Abstract] [Full Text] [Related]
19. Coagulation factor XIII in scleroderma. Jullien D; Souillet AL; Faure M; Claudy A Eur J Dermatol; 1998 Jun; 8(4):231-4. PubMed ID: 9649677 [TBL] [Abstract][Full Text] [Related]